An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review.

BACKGROUND Several epidemiological studies have suggested an association between cutaneous melanoma and non-Hodgkin's lymphoma. METHODS We pooled the data from seven cohort studies and calculated the risk of secondary occurrence of cutaneous melanoma after non-Hodgkin's lymphoma, and of non-Hodgkin's lymphoma subsequent to the occurrence of cutaneous melanoma. RESULTS There were 137 612 patients with primary non-Hodgkin's lymphoma and 109 532 patients with primary cutaneous melanoma. We found a statistically significant increased risk of non-Hodgkin's lymphoma among cutaneous melanoma survivors [standardised incidence ratio (SIR) 2.01, 95% confidence interval (CI) 1.79-2.24] and cutaneous melanoma among non-Hodgkin's lymphoma survivors (SIR 1.41, 95% CI 1.26-1.58). CONCLUSION Our study confirmed an association between cutaneous melanoma and non-Hodgkin's lymphoma occurring in the same patient indicative of a need to examine further the role of the common risk factors.

[1]  AJ McMichael,et al.  Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? , 1996, British Journal of Cancer.

[2]  L. Sandkuijl,et al.  Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. , 2001, American journal of human genetics.

[3]  K. Hemminki,et al.  Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958–1996: a search for common mechanisms , 2001, British Journal of Cancer.

[4]  J. Medema,et al.  Relationship between ultraviolet radiation-induced immunosuppression and carcinogenesis. , 1994, The Journal of investigative dermatology.

[5]  D. Brewster,et al.  Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland , 2003, British Journal of Cancer.

[6]  J. Olsen,et al.  Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80. , 1985, National Cancer Institute monograph.

[7]  E. Saxén,et al.  Multiple cancer--an epidemiologic exercise in Finland. , 1985, Journal of the National Cancer Institute.

[8]  D. Finkelstein,et al.  Evidence for an association between cutaneous melanoma and non‐Hodgkin lymphoma , 2001, Cancer.

[9]  H. Storm,et al.  Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80. , 1985, National Cancer Institute monograph.

[10]  P. Hall,et al.  Risk of non-Hodgkin's lymphoma and skin malignancies in patients diagnosed with cataract , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[11]  D. Sidransky,et al.  Exon 15 BRAF Mutations Are Uncommon in Melanomas Arising in Nonsun-Exposed Sites , 2004, Clinical Cancer Research.

[12]  L. Fielding,et al.  The association between melanoma, lymphoma, and other primary neoplasms. , 1995, Archives of surgery.

[13]  C. Bucana,et al.  Deficient antigen presentation and Ts induction are separate effects of ultraviolet irradiation. , 1995, Cellular immunology.

[14]  C. la Vecchia,et al.  Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers. , 1996, British Journal of Cancer.

[15]  J. Hunter,et al.  Malignant melanoma and lymphoproliferative malignancy: is there a shared aetiology? , 2000, The British journal of dermatology.

[16]  J. Werkmeister,et al.  Suppressor cell activity in melanoma patients. II. Concanavalin A‐induced suppressor cells in relation to tumor growth and suppressor T‐cell subsets , 1981, International journal of cancer.

[17]  D. Bishop,et al.  A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. , 2001, Human molecular genetics.

[18]  B. Armstrong,et al.  The epidemiology of UV induced skin cancer. , 2001, Journal of photochemistry and photobiology. B, Biology.

[19]  E. Gillanders,et al.  Localization of a novel melanoma susceptibility locus to 1p22. , 2003, American journal of human genetics.

[20]  A. Howell,et al.  Germline mutation of ARF in a melanoma kindred. , 2002, Human molecular genetics.

[21]  R. Fisher,et al.  Increased sensitivity of T cells to regulation by normal suppressor cells persists in long-term survivors with Hodgkin's disease. , 1982, The American journal of medicine.

[22]  M. Tucker,et al.  Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82. , 1985, National Cancer Institute monograph.

[23]  Ajay N. Jain,et al.  Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.

[24]  Florence Demenais,et al.  Geographical variation in the penetrance of CDKN2A mutations for melanoma. , 2002, Journal of the National Cancer Institute.

[25]  M. Melbye,et al.  Evidence of an association between non-Hodgkin's lymphoma and skin cancer , 1995, BMJ.

[26]  M. Greene,et al.  Second cancer following lymphatic and hematopoietic cancers in Connecticut, 1935-82. , 1985, National Cancer Institute monograph.

[27]  R. Marks,et al.  Epidemiology of melanoma , 2000, Clinical and experimental dermatology.

[28]  S. Wacholder,et al.  Second cancers among long-term survivors of non-Hodgkin's lymphoma. , 1993, Journal of the National Cancer Institute.

[29]  P. Brennan,et al.  Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia , 2000, British Journal of Cancer.

[30]  R. Newton.  American data refute ultraviolet hypothesis , 1995, BMJ.

[31]  P. Sasieni,et al.  Non-Hodgkin's lymphoma and skin cancer , 1995, BMJ.

[32]  C. Begg,et al.  Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program. , 1995, American journal of epidemiology.

[33]  P. Hall,et al.  Non‐Hodgkin's lymphoma and skin malignancies‐shared etiology? , 1995, International journal of cancer.

[34]  J. Cerhan,et al.  Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[35]  H. Redmond,et al.  Synchronous high-risk melanoma and lymphoid neoplasia , 2001, Melanoma research.

[36]  J. Kaldor,et al.  Sun exposure may protect against non‐Hodgkin lymphoma: A case‐control study , 2004, International journal of cancer.

[37]  M H Skolnick,et al.  Familiality of cancer in Utah. , 1994, Cancer research.

[38]  K. Hemminki,et al.  Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. , 2001 .

[39]  S. Devesa,et al.  Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. , 2000, Journal of the National Cancer Institute.

[40]  T. Fears,et al.  Non-Hodgkin's lymphoma time trends: United States and international data. , 1992, Cancer research.

[41]  G. Bentham.  Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales , 1996, BMJ.